Compugen Management
Management criteria checks 2/4
Compugen's CEO is Anat Cohen-Dayag, appointed in Jun 2009, has a tenure of 15.25 years. total yearly compensation is $1.46M, comprised of 32.7% salary and 67.3% bonuses, including company stock and options. directly owns 0.063% of the company’s shares, worth ₪377.71K. The average tenure of the management team and the board of directors is 4.8 years and 7.2 years respectively.
Key information
Anat Cohen-Dayag
Chief executive officer
US$1.5m
Total compensation
CEO salary percentage | 32.7% |
CEO tenure | 15.3yrs |
CEO ownership | 0.06% |
Management average tenure | 4.8yrs |
Board average tenure | 7.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$10m |
Mar 31 2024 | n/a | n/a | -US$17m |
Dec 31 2023 | US$1m | US$479k | -US$19m |
Sep 30 2023 | n/a | n/a | -US$32m |
Jun 30 2023 | n/a | n/a | -US$33m |
Mar 31 2023 | n/a | n/a | -US$33m |
Dec 31 2022 | US$1m | US$479k | -US$34m |
Sep 30 2022 | n/a | n/a | -US$39m |
Jun 30 2022 | n/a | n/a | -US$34m |
Mar 31 2022 | n/a | n/a | -US$34m |
Dec 31 2021 | US$1m | US$498k | -US$34m |
Sep 30 2021 | n/a | n/a | -US$34m |
Jun 30 2021 | n/a | n/a | -US$36m |
Mar 31 2021 | n/a | n/a | -US$32m |
Dec 31 2020 | US$1m | US$453k | -US$30m |
Sep 30 2020 | n/a | n/a | -US$28m |
Jun 30 2020 | n/a | n/a | -US$26m |
Mar 31 2020 | n/a | n/a | -US$26m |
Dec 31 2019 | US$941k | US$395k | -US$27m |
Sep 30 2019 | n/a | n/a | -US$30m |
Jun 30 2019 | n/a | n/a | -US$27m |
Mar 31 2019 | n/a | n/a | -US$31m |
Dec 31 2018 | US$854k | US$391k | -US$23m |
Sep 30 2018 | n/a | n/a | -US$23m |
Jun 30 2018 | n/a | n/a | -US$29m |
Mar 31 2018 | n/a | n/a | -US$28m |
Dec 31 2017 | US$740k | US$392k | -US$37m |
Compensation vs Market: Anat's total compensation ($USD1.46M) is above average for companies of similar size in the IL market ($USD660.55K).
Compensation vs Earnings: Anat's compensation has increased whilst the company is unprofitable.
CEO
Anat Cohen-Dayag (57 yo)
15.3yrs
Tenure
US$1,464,448
Compensation
Dr. Anat Cohen-Dayag, Ph D., served as an Independent Director at Gamida Cell Ltd since January 28, 2022 until March 2023. She serves as Director at has been Chief Executive Officer and President at Compug...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 15.3yrs | US$1.46m | 0.063% $ 377.7k | |
Chief Scientific Officer | 4.5yrs | US$540.64k | no data | |
Senior Vice President of Technology Innovation | 6.7yrs | US$532.26k | no data | |
Vice President of Preclinical Development | 3.4yrs | US$570.40k | no data | |
Chief Financial Officer | less than a year | no data | no data | |
Head of Investor Relations & Corporate Communications | no data | no data | no data | |
General Counsel & Corporate Secretary | 5.7yrs | no data | no data | |
Vice President of Human Resources | 17.7yrs | no data | no data | |
Senior VP & Senior Advisor of Data and Informatics Solutions | 4.8yrs | no data | no data | |
Vice President Research and Discovery | no data | no data | no data | |
Chief Medical Officer | less than a year | no data | no data |
4.8yrs
Average Tenure
53yo
Average Age
Experienced Management: CGEN's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 10.6yrs | US$1.46m | 0.063% $ 377.7k | |
Member of Scientific Advisory Board | 4yrs | no data | no data | |
Independent Director | 6.3yrs | no data | no data | |
Member of Scientific Advisory Board | 11.1yrs | no data | no data | |
Independent Director | 6.3yrs | no data | no data | |
Independent Chairman of the Board | 6.9yrs | no data | no data | |
Independent Director | 6.3yrs | no data | no data | |
Chairman of Scientific Advisory Board | 10.7yrs | no data | no data | |
Member of Scientific Advisory Board | 11.1yrs | no data | no data | |
Independent Director | 5.2yrs | no data | no data | |
Member of Scientific Advisory Board | 11.1yrs | no data | no data | |
Member of Scientific Advisory Board | 7.5yrs | no data | no data |
7.2yrs
Average Tenure
58yo
Average Age
Experienced Board: CGEN's board of directors are considered experienced (7.2 years average tenure).